MarginsXMarginsX
Home › Markets › Health Care › GLAS

Glass House Brands Inc. Subordinate Voting Shares (GLAS)

GLAS trades on NYSE in Health Care, Medicinal Chemicals and Botanical Products . Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$1.29
+1.57% on the day
Market cap
$113.5M
Micro cap
Revenue · 2025
$182.0M
-9.4% on 2024
Net income · 2025
-$29.7M
-16.3% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 40-F (us-gaap:Revenues), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1848731/000184873126000015/0001848731-26-000015-index.htm. Net income: SEC 40-F (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerGLAS on NYSE
SectorHealth Care
Industry Medicinal Chemicals and Botanical Products
CountryNot reported by the screener
IPO yearNot reported by the screener
SEC CIK0001848731
SEC industry codeMedicinal Chemicals & Botanical Products
Incorporated inBC

Financials · 2025

LineValue
Revenue$182.0M
Net income-$29.7M
Operating income-$16.5M
Net margin-16.3%
Operating margin-9.1%
Revenue growth-9.4%
Cash$23.4M
Total assets$318.6M
P/E (computed)Net income was not positive
P/S (computed)0.6×

Warning signs

Cash runway
Cash-flow positive
$23.4M cash at December 31, 2025
Share count, 1 year
See the dilution note
Going-concern doubt
No
40-F filed March 24, 2026
Insider net buying, 12 months
-$354K
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.40-F 2026-03-24
Cash and burn$23.4M cash; operating cash flow $2.9M a quarter.Report 2025-12-31
Shares outstanding80,037,887 (2025-12-31). the newest SEC cover-page count is from 2025-12-31; shares issued since then are not in these figures.Cover page 2025-12-31
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorMacias Gini & O'Connell LLP, Irvine, California, United StatesPCAOB Form AP 2026-04-01
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $354K on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Annual results

Fiscal yearRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
FY 2025
2025-12-31
$182.0M-$29.7M$11.4M$23.4M$68.7M$182.0M40-F 2026-03-24
FY 2024
2024-12-31
$200.9M$519K$28.4M$36.9M$58.2M$200.9M40-F 2026-03-24
FY 2023
2023-12-31
$160.8M-$98.3M$23.2M$32.5M$64.1M$160.8M40-F 2025-03-25
FY 2022
2022-12-31
$84.9M-$32.9M-$40.8M$14.1M$62.7M$84.9M40-F/A 2024-04-02
FY 2021
2021-12-31
$63.2M-$43.1M-$20.3M$54.1M$44.9M$63.2M40-F/A 2024-04-02
FY 2020
2020-12-31
$48.3M-$16.7M-$7.7M$4.5M$16.0M$48.3M40-F/A 2022-04-01

From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest annual report40-F2026-03-24
Latest quarterly / interim6-K2026-11-16

Source: SEC EDGAR submissions feed, 197 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-38.9%
1 month-67.0%
3 months-87.3%
Year to date-85.6%
1 year-81.9%
From 52-week high-90.6%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medicinal Chemicals and Botanical Products

TickerCompanyPriceDayMarket cap
ISPRIspire Technology Inc.$1.52-10.06%$87.8M
NAGENiagen Bioscience Inc.$2.01-2.66%$159.2M
MDWDMediWound Ltd.$13.55+5.04%$195.0M
FTLFFitLife Brands Inc.$6.83-19.46%$64.1M
CGCCanopy Growth Corporation Common Shares$0.5460-2.71%$231.2M
USNAUSANA Health Sciences Inc.$13.54+2.27%$250.3M
ACBAurora Cannabis Inc. Common Shares$4.61-6.68%$303.1M
SNDLSNDL Inc. Common Shares$1.34-2.19%$326.0M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier